Browse > Article
http://dx.doi.org/10.14253/kjcn.2014.16.2.81

A Case of Adult Onset Glycogen Storage Myopathy  

Shin, Jung Hwan (Department of Neurology, Seoul National University College of Medicine)
Kim, Dong Gun (Department of Neurology, Seoul National University College of Medicine)
Shin, Je Young (Department of Neurology, Seoul National University College of Medicine)
Park, Sung Hye (Department of Pathology, Seoul National University College of Medicine)
Lee, Kwang Woo (Department of Neurology, Seoul National University College of Medicine)
Publication Information
Annals of Clinical Neurophysiology / v.16, no.2, 2014 , pp. 81-85 More about this Journal
Abstract
Primary metabolic myopathy as a type of congenital myopathies was first described by McArdle in 1951. Glycogen storage disease is a disease caused by genetic mutations involved in glycogen synthesis, glycogenolysis or glycolysis. Several types of glycogen storage disease are known to cause metabolic myopathies. We report a case of adult onset metabolic myopathy with glycogen storage.
Keywords
Myopathy; Glycogen storage disease; Metabolic myopathy;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Burr ML, Roos JC, Ostor AJ. Metabolic myopathies: a guide and update for clinicians. Current opinion in rheumatology 2008;20:639-647.   DOI   ScienceOn
2 Haller RG, Vissing J. Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms. Arch Neurol 2002;59:1395-1402.
3 Haller RG, Vissing J. No spontaneous second wind in muscle phosphofructokinase deficiency. Neurology 2004;62:82-86.   DOI   ScienceOn
4 Toscano A, Musumeci O. Tarui disease and distal glycogenoses: clinical and genetic update. Acta myologica: myopathies and cardiomyopathies: official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases 2007;26: 105-107.
5 Noel N, Flanagan JM, Ramirez Bajo MJ, Kalko SG, Manu Mdel M, Garcia Fuster JL, et al. Two new phosphoglycerate kinase mutations associated with chronic haemolytic anaemia and neurological dysfunction in two patients from Spain. British journal of haematology 2006;132:523-529.
6 Berardo A, DiMauro S, Hirano M. A diagnostic algorithm for metabolic myopathies. Current neurology and neuroscience reports 2010;10:118-126.   DOI   ScienceOn
7 Toda G, Yoshimuta T, Kawano H, Yano K. Glycogen storage disease associated with left ventricular aneurysm in an elderly patient. Jpn Circ J 2001;65:462-464.   DOI   ScienceOn
8 Andersen ST, Haller RG, Vissing J. Effect of oral sucrose shortly before exercise on work capacity in McArdle disease. Arch Neurol-Chicago 2008;65:786-789.
9 Martinuzzi A, Liava A, Trevisi E, Frare M, Tonon C, Malucelli E, et al. Randomized, placebo-controlled, doubleblind pilot trial of ramipril in McArdle's disease. Muscle Nerve 2008;37:350-357.   DOI   ScienceOn
10 Kishnani PS, Corzo D, Nicolino M, Byrne B, Mandel H, Hwu WL, et al. Recombinant human acid alpha-glucosidase - Major clinical benefits in infantile-onset Pompe disease. Neurology 2007;68:99-109.   DOI   ScienceOn